IRIS

The features and management of acquired resistance to PD1-based therapy in metastatic melanoma / Hepner, A; Versluis, Jm; Wallace, R; Allayous, C; Brown, Lj; Trojaniello, C; Gerard, Cl; Jansen, Yj; Bhave, P; Neyns, B; Haydon, A; Michielin, O; Mangana, J; Klein, O; Shoushtari, An; Warner, Ab; Ascierto, Pa; Mcquade, Jl; Carlino, Ms; Zimmer, L; Lebbe, C; Johnson, Db; Sandhu, S; Atkinson, V; Blank, Cu; Lo, Sn; Long, Gv; Menzies, Am. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - (2024). [10.1016/j.ejca.2023.113441]

The features and management of acquired resistance to PD1-based therapy in metastatic melanoma

Trojaniello C;Ascierto PA;Johnson DB;
2024
2024
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma / Hepner, A; Versluis, Jm; Wallace, R; Allayous, C; Brown, Lj; Trojaniello, C; Gerard, Cl; Jansen, Yj; Bhave, P; Neyns, B; Haydon, A; Michielin, O; Mangana, J; Klein, O; Shoushtari, An; Warner, Ab; Ascierto, Pa; Mcquade, Jl; Carlino, Ms; Zimmer, L; Lebbe, C; Johnson, Db; Sandhu, S; Atkinson, V; Blank, Cu; Lo, Sn; Long, Gv; Menzies, Am. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - (2024). [10.1016/j.ejca.2023.113441]
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1017614
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact